Yale researchers to present new data on novel treatment for drug-resistant brain cancers at AACR Meeting
Yale Cancer Center/Smilow Cancer Hospital
In a new study published in The FASEB Journal, investigators demonstrated the potential of a molecule that may help overcome some of the devastating symptoms of Duchenne muscular dystrophy (DMD), the most common life-limiting congenital neuromuscular disorder. The agent promotes the activity of AMP-activated protein kinase (AMPK), an important fuel-sensing enzyme that is present in all mammalian cells.
Spinal cord stimulation (SCS) has demonstrated effectiveness for neuropathic pain. Unfortunately, some patients report inadequate long-term pain relief. Patient selection is emphasized for this therapy; however, the prognostic capabilities and deployment strategies of existing selection techniques, including an SCS trial, have been questioned.
Depression is widely reported to be more common in women than in men, with women twice as likely to receive a diagnosis than men.
Warming a crystal of the mineral fresnoite, Oak Ridge National Laboratory scientists discovered that excitations called phasons carried heat three times farther and faster than phonons, the excitations that usually carry heat through a material.
In an analysis published in the British Journal of Management that included 592 firms from 35 countries operating from 2002–2019, higher levels of greenhouse gas emissions were negatively associated with market value, whereas climate change initiatives were positively linked with market value.